By using an undetermined method in its transfer pricing analysis to determine royalty rates for licence agreements, the Tax Court's ruling in Medtronic III provides guidance for future related-party transactions.
By using an undetermined method in its transfer pricing analysis to determine royalty rates for licence agreements, the Tax Court's ruling in Medtronic III provides guidance for future related-party transactions.